The Italy–China bilateral conference on Precision Medicine promoted by the HEAL Italia Foundation in collaboration with CDDpress, which will take place on April 23–24, 2026 at the “South Half Garden” in Suzhou, Jiangsu Province, China, represents an important opportunity for dialogue and collaboration between two leading scientific and healthcare realities at the international level. In an era in which technological innovation and biomedical research are revolutionizing the way diseases are prevented, diagnosed, and treated, precision medicine is emerging as one of the fundamental pillars of the future of healthcare. This meeting was created with the aim of fostering the exchange of knowledge, experiences, and best practices among experts, researchers, and institutions from the two countries, promoting strategic synergies in the fields of genomics, artificial intelligence applied to medicine, and personalized therapies. Italy and China, drawing on their respective scientific excellence and diverse cultural perspectives, can contribute in a complementary way to the development of innovative patient-oriented solutions. Indeed, Precision Medicine represents a scientific and cultural choice for the future of medicine, placing the individual at the center and addressing in a personalized way every aspect that influences health, not limiting itself to intervening on the disease.
We are, in fact, witnessing the transition from “one-size-fits-all” medicine to “medicine for each individual,” in which clinical decisions are guided by a deep understanding of the patient’s biological profile, through the structured integration of omics, clinical, environmental, and digital data.
These services will need to be steadily integrated into daily clinical practice, with the objective of building diagnostic and therapeutic pathways tailored to the individual characteristics of each patient, overcoming the uniformity of the traditional approach. The transition towards this innovative model will not only make it possible to significantly improve clinical outcomes, but also to provide concrete responses to contemporary healthcare and social challenges, such as population aging and the increasing complexity of care needs. On April 23 and 24, 2026, through thematic sessions and moments of discussion, the conference aims not only to explore the most recent developments in precision medicine, but also to strengthen international cooperation ties, creating the foundations for future collaborations in the clinical and research fields.
